Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nutritional modulators of bone remodeling during aging.

Gregory R Mundy1

  • 1University of Texas Health Science Center at San Antonio, Texas 78229-3900, USA. mundy@uthscsa.edu

The American Journal of Clinical Nutrition
|February 14, 2006
PubMed
Summary

As bone mass declines with age, osteoporosis risk increases. Dietary interventions stimulating bone morphogenetic protein 2 (BMP2) show promise for enhancing bone formation and preventing osteoporosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The polyphenol resveratrol promotes skeletal growth in mice through a sirtuin 1-bone morphogenic protein 2 longevity axis.

British journal of pharmacology·2018
Same author

Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells.

Journal of cell science·2013
Same author

Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2012
Same author

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

PloS one·2012
Same author

Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.

Cancer research·2012
Same author

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.

Cancer research·2012

Area of Science:

  • Biochemistry
  • Gerontology
  • Nutrition Science

Background:

  • Bone mass naturally decreases with age starting around 30 years.
  • Increased longevity is associated with higher rates of osteoporosis and related healthcare costs.
  • Current osteoporosis treatments primarily inhibit bone resorption, with limited bone mass improvement.

Purpose of the Study:

  • To explore molecular targets for stimulating bone formation.
  • To investigate the role of bone morphogenetic proteins (BMPs), specifically BMP2, in bone health.
  • To examine the potential of dietary interventions to influence bone mass and prevent osteoporosis.

Main Methods:

  • Reviewing research on cellular events in bone formation.
  • Analyzing the link between the BMP2 gene and osteoporosis.
  • Investigating dietary compounds like flavonoids and statins that affect BMP2.
  • Assessing the impact of dietary stimulation of the BMP2 promoter on bone formation.

Main Results:

  • Bone morphogenetic proteins (BMPs) are identified as stimulators of bone formation.
  • The BMP2 gene has been associated with osteoporosis.
  • Dietary components, including flavonoids and statins, can stimulate the BMP2 promoter.
  • These dietary factors show positive effects on bone formation.

Conclusions:

  • Targeting BMP2 offers a potential strategy for developing new bone-forming agents.
  • Dietary interventions may influence peak bone mass and reduce future osteoporosis risk.
  • Preventive strategies, particularly dietary ones, are crucial for mitigating the future burden of osteoporosis.

Related Experiment Videos